Skip to main content
Caplight Logo









EnteroTrack

EnteroTrack

Private
Aurora, ColoradoHealthcare & Life Scienceshttps://enterotrack.com/

Last Round

Seed

Sep 25, 2026

Total Funding Raised

$250,000

Momentum

Top 5%

of companies Caplight tracks

Company Overview

EnteroTrack is a medical device company that develops non-invasive capsule-based diagnostic tools for sampling and monitoring gastrointestinal conditions such as eosinophilic esophagitis.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

medical devicegastrointestinal diagnosticsliquid biopsynon-invasive diagnosticsesophageal string testgastroenterologyEoEeosinophilic esophagitisminimally invasivediagnostic devicecapsule endoscopypill campoint of carebiomarker analysisendoscopy alternative

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EnteroTrack Comparables

Compare EnteroTrack with similar companies based on industry and business-model similarity.

EnteroTrack comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cyted Health
76%
PAVmed Inc.
75%
Medtronic
74%

EnteroTrack Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 25, 2026
AngelJul 9, 2014

Key People

Founding team and executive leadership

Robin Shandas

Chief Executive Officer

Executive Team

EnteroTrack Investors

Notable investors and investment history

EnteroTrack investors
InvestorRounds
Creative Destruction LabAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 25, 2026

    $2M raised in Seed Round.

  • Jun 18, 2026

    Monthly visitors increased 45% MoM.

EnteroTrack Filings

Explore SEC and related filing metadata, where available.

EnteroTrack filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about EnteroTrack's valuation, stock price, and market status.

Is EnteroTrack a public or private company?

EnteroTrack is a private company.

What is the current stock price of EnteroTrack?

EnteroTrack is a private company, so its shares have no public market price. Caplight tracks EnteroTrack's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is EnteroTrack worth (valuation)?

Valuation information for EnteroTrack is not publicly available.

Can I buy EnteroTrack stock?

EnteroTrack shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was EnteroTrack's last funding round?

EnteroTrack's most recent funding round was Seed on September 25, 2026.

Who are the main investors in EnteroTrack?

Key investors in EnteroTrack include Creative Destruction Lab.

Will EnteroTrack IPO soon?

No public IPO plans have been announced for EnteroTrack.

How can I track EnteroTrack secondary market activity?

Caplight tracks bids, offers, and trades in EnteroTrack's shares on secondary markets.

Firmographic Details

HeadquartersAurora, Colorado
Employee Range11
Year Founded2013
Last FundingSep 25, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?